Compare BridgeBio Pharma Inc (BBIO) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Zoom Video Communications, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Zoom Video Communications, Inc. trades at $105.67 (market cap $31.10B). The key difference: Zoom Video Communications, Inc. is the larger of the two by market cap. Which is the better fit depends on your goals.
| BBIO | ZM | |
|---|---|---|
Market Cap | $16.36B | $31.10B |
Sector | Health | Technology |
52-Week High | $90.17 | $111.88 |
52-Week Low | $47.29 | $69.96 |
Enterprise Value | $18.14B | $23.44B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
